Remicade (infliximab), a new biotech drug for Crohn's disease

Centocor will market Remicade (infliximab), a new biotech drug for Crohn's disease.

It's a monoclonal antibody that neutralizes the activity of tumor necrosis factor...a protein that promotes inflammation.

Remicade is also being tested for other inflammatory conditions such as rheumatoid arthritis.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote